Effect of Hands and Feet Exercises on Taxane Based Chemotherapy Induced Peripheral Neuropathy in Patients With Solid Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-03-01

Study Completion Date

2026-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to determine whether hand and foot exercises can reduce the severity of Taxane-based chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer patients aged 20-60 years who have Grade 1I neuropathy as defined by the NCI-CTCAE criteria.

The main questions it aims to answer are:

* Do hand and foot exercises reduce the severity of sensory and motor neuropathic symptoms in patients receiving Taxane based chemotherapy?
* Is the severity of peripheral neuropathy lower in the exercise group compared to patients receiving standard care alone? Researchers will compare patients receiving standard care (control group) with those receiving standard care plus a structured hand and foot exercise program (experimental group) to see if the exercises lead to greater improvement in neuropathy severity scores.

Participants will:

* Receive baseline assessment using the EORTC QLQ-CIPN20 questionnaire.
* In the experimental group, learn and perform a 15-minute hand and foot exercise routine on chemotherapy day and continue it at home using a provided brochure.
* Participate in telephonic follow-ups to support compliance and monitor symptoms.
* Undergo a follow-up assessment at alternate week to measure changes in neuropathy severity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients

NCT06737926

Chemotherapy Induced Peripheral Neuropathy Breast Cancer Patients

RECRUITING NA

Effect of Exercise in the Management of Peripheral Neuropathy

NCT04843410

Chemotherapy-induced Peripheral Neuropathy Chemotherapeutic Toxicity

COMPLETED NA

Hand-Foot Exercises on Peripheral Neuropathy

NCT06055088

Breast Cancer Neuropathy

COMPLETED NA

Task-oriented Training on Hand Function in Taxanes-induced Peripheral Neuropathy

NCT06632626

Peripheral Neuropathy Chemotherapy Effect Hand Function

COMPLETED NA

Home-Based Physical Activity Intervention for Taxane-Induced CIPN

NCT04621721

Breast Cancer Female Chemotherapy-induced Peripheral Neuropathy Gait Disorders, Neurologic +2 more

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study focuses on adults between 20 and 60 years old who are receiving Taxane chemotherapy and have early-stage (Grade II) neuropathy. At this stage, patients usually notice changes in sensation, but these changes are still manageable. By starting exercises early, the study aims to see whether regular movement of the hands and feet can help reduce the intensity of these symptoms over time.

Participants will be randomly assigned to one of two groups. One group will continue with their routine medical care for neuropathy, which may include medication and guidance from their healthcare team. The other group will receive the same standard care but will also be taught a short set of hand and foot exercises. These exercises take around 15 minutes to complete and are performed once a day. Patients in the exercise group will first learn the routine on the day of their chemotherapy session and will receive a brochure so they can continue the exercises at home. Telephone check-ins will be used to support patients, answer questions, and encourage regular practice.

To understand how symptoms change, all participants will complete a questionnaire called the EORTC QLQ-CIPN20 at the beginning of the study and again after several weeks. This tool helps measure nerve-related symptoms and how much they affect daily life. The results will allow the research team to compare how symptoms change in both groups over the course of the study.

By examining whether a simple, low-cost exercise routine can make a meaningful difference, this study hopes to offer cancer patients a practical way to manage neuropathy alongside their chemotherapy. If effective, these exercises could become a helpful addition to supportive care in oncology settings, improving comfort and quality of life during treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Neuropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomly assigned in a 1:1 ratio to one of two parallel arms and will remain in that assigned arm for the duration of the study.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Care (Control)

Standard care

Group Type NO_INTERVENTION

No interventions assigned to this group

Hand and Foot Exercise Program + Standard Care (Experimental)

Structured Hand and Foot Exercises and standard care

Group Type EXPERIMENTAL

Structured Hand and Foot Exercises

Intervention Type OTHER

The intervention consists of a structured hand and foot exercise program specifically designed for patients experiencing chemotherapy-induced peripheral neuropathy during Taxane-based treatment. It is distinct from general physiotherapy or mobility exercises because it targets peripheral nerve function, joint mobility, and circulation in the hands and feet, aiming to reduce the severity of neuropathic symptoms.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Structured Hand and Foot Exercises

The intervention consists of a structured hand and foot exercise program specifically designed for patients experiencing chemotherapy-induced peripheral neuropathy during Taxane-based treatment. It is distinct from general physiotherapy or mobility exercises because it targets peripheral nerve function, joint mobility, and circulation in the hands and feet, aiming to reduce the severity of neuropathic symptoms.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cancer patients receiving taxane-based chemotherapy on alternate week.
* Age 20-60 years, both male and female.
* Patients having Grade I neuropathy by NCI-CTCEA criteria.

Exclusion Criteria

* Patients with peripheral neuropathy not caused by chemotherapy.

* Patient with type-1 and type- 2 diabetes.
* Patients with neuropsychiatric disorders.
* Patients having any skin ulcer.
* Individuals having hand foot fracture and varicose veins.
* Individuals with paraplegia.
* Patients receiving radiotherapy.

Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No